Stay updated with breaking news from Bridge Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Funding will progress Orionis' tunable precision medicines pipeline, with anticipated IND submission and start of conditionally active cytokine Phase 1 trial in 2023 Robert Petit joins as Head of
AVROBIO leading industry in combining use of two safety assays to evaluate genotoxicity risk prior to moving into clinical trials New safety assay uses machine learning algorithms and transcriptional
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that it will present new preclinical data on novel
Stage one efficacy threshold achieved in dose expansion in patients with squamous cell carcinoma of the head and neck Webinar to review data to be held Monday, September 12th at 10:30 a.m. ET, featuring
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2022 -- Tenaya Therapeutics, Inc. , a clinical-stage biotechnology company with a mission to discover, develop and deliver curative therapies that address the... | September 6, 2022